DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Iizuka T, Iemitsu K, Takihata M. et al.
Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study.
J Clin Med Res 2016;
8: 116-125
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.